The Heng/Wulf team abstract, "Biological sex-linked immune modulation but not cross-sex estrogen therapy reduces the efficacy of PARP inhibition in the treatment of Brca1 breast tumors" has been selected for Poster Spotlight presentation at the SABCS 2024.